GUILLERMO
LÓPEZ VIVANCO
Chercheur jusqu' 2022
Institute Catalá Oncología
Barcelona, EspañaPublications en collaboration avec des chercheurs de Institute Catalá Oncología (9)
2023
-
Immunogenicity of COVID-19 vaccines in lung cancer patients
Lung Cancer, Vol. 184
-
Perioperative Nivolumab and Chemotherapy in Stage III Non-Small-Cell Lung Cancer
New England Journal of Medicine, Vol. 389, Núm. 6, pp. 504-513
2022
-
Seroprevalence and immunological memory against SARS-CoV-2 in lung cancer patients: the SOLID study
Translational Lung Cancer Research, Vol. 11, Núm. 1, pp. 53-63
2021
-
First-line osimertinib in patients with epidermal growth factor receptor–mutant non–small-cell lung cancer and with a coexisting low allelic fraction of Thr790Met
European Journal of Cancer, Vol. 159, pp. 174-181
2018
-
Long-term response to first-line bevacizumab-based therapy in patients with metastatic breast cancer: Results of the observational “LORENA” study
OncoTargets and Therapy, Vol. 11, pp. 5845-5852
2012
2010
-
Blood-based CHRNA3 single nucleotide polymorphism and outcome in advanced non-small-cell lung cancer patients
Lung Cancer, Vol. 68, Núm. 3, pp. 491-497
2009
-
Customized Treatment in Non-Small-Cell Lung Cancer Based on EGFR Mutations and BRCA1 mRNA Expression
PLoS ONE, Vol. 4, Núm. 5
2003
-
Three-week schedule of irinotecan and cisplatin in advanced non-small cell lung cancer: A multicentre phase II study
Lung Cancer, Vol. 39, Núm. 2, pp. 201-207